Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUM015 imaging probe for gastrointestinal cancers
NCT02584244Phase 2Recruiting
- Sponsor
- Lumicell
- Start
- Aug 2016
- Primary completion
- Dec 2026
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of pegulicianine, sponsored by Lumicell. Started Aug 2016; status: recruiting.
02
Drugs
pegulicianine
Beyond the preview
Go deeper on NCT02584244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584244.